Literature DB >> 29405197

Bridging the gap: are animal models consistent with clinical cancer cachexia?

Vickie E Baracos1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29405197     DOI： 10.1038/nrclinonc.2018.14

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  11 in total

1.  Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia.

Authors:  Aaron Winter; Jacqueline MacAdams; Stéphanie Chevalier
Journal:  Clin Nutr       Date:  2012-05-29       Impact factor: 7.324

2.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

Authors:  Jurre J Kamphorst; Michel Nofal; Cosimo Commisso; Sean R Hackett; Wenyun Lu; Elda Grabocka; Matthew G Vander Heiden; George Miller; Jeffrey A Drebin; Dafna Bar-Sagi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2015-02-01       Impact factor: 12.701

3.  Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.

Authors:  A Miller; L McLeod; S Alhayyani; A Szczepny; D N Watkins; W Chen; P Enriori; W Ferlin; S Ruwanpura; B J Jenkins
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

4.  Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.

Authors:  Samuel N Breit; Vicky Wang-Wei Tsai; David A Brown
Journal:  Trends Mol Med       Date:  2017-11-09       Impact factor: 11.951

5.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.

Authors:  Serkan Kir; James P White; Sandra Kleiner; Lawrence Kazak; Paul Cohen; Vickie E Baracos; Bruce M Spiegelman
Journal:  Nature       Date:  2014-07-13       Impact factor: 49.962

6.  Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.

Authors:  Chen Chen; Fabio C Tucci; Wanlong Jiang; Joe A Tran; Beth A Fleck; Sam R Hoare; Jenny Wen; Takung Chen; Michael Johns; Stacy Markison; Alan C Foster; Dragan Marinkovic; Caroline W Chen; Melissa Arellano; John Harman; John Saunders; Haig Bozigian; Daniel Marks
Journal:  Bioorg Med Chem       Date:  2008-04-01       Impact factor: 3.641

Review 7.  Cancer-associated cachexia.

Authors:  Vickie E Baracos; Lisa Martin; Murray Korc; Denis C Guttridge; Kenneth C H Fearon
Journal:  Nat Rev Dis Primers       Date:  2018-01-18       Impact factor: 52.329

8.  Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.

Authors:  Marco Segatto; Raffaella Fittipaldi; Fabrizio Pin; Roberta Sartori; Kyung Dae Ko; Hossein Zare; Claudio Fenizia; Gianpietro Zanchettin; Elisa Sefora Pierobon; Shinji Hatakeyama; Cosimo Sperti; Stefano Merigliano; Marco Sandri; Panagis Filippakopoulos; Paola Costelli; Vittorio Sartorelli; Giuseppina Caretti
Journal:  Nat Commun       Date:  2017-11-22       Impact factor: 14.919

9.  Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus.

Authors:  Carlos A Campos; Anna J Bowen; Sung Han; Brent E Wisse; Richard D Palmiter; Michael W Schwartz
Journal:  Nat Neurosci       Date:  2017-06-05       Impact factor: 24.884

10.  Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia.

Authors:  Ashok Narasimhan; Sunita Ghosh; Cynthia Stretch; Russell Greiner; Oliver F Bathe; Vickie Baracos; Sambasivarao Damaraju
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-01-06       Impact factor: 12.910
View more
  7 in total

Review 1.  The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia.

Authors:  Brandon N VanderVeen; E Angela Murphy; James A Carson
Journal:  Front Physiol       Date:  2020-08-31       Impact factor: 4.566

2.  Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer.

Authors:  Cong-Kai Luo; Pei-Hsuan Chou; Shang-Kok Ng; Wen-Yen Lin; Tzu-Tang Wei
Journal:  Cancer Gene Ther       Date:  2021-05-18       Impact factor: 5.987

3.  Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.

Authors:  Rachel L Nosacka; Andrea E Delitto; Dan Delitto; Rohan Patel; Sarah M Judge; Jose G Trevino; Andrew R Judge
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-10       Impact factor: 12.910

Review 4.  MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia.

Authors:  Gioacchino P Marceca; Giovanni Nigita; Federica Calore; Carlo M Croce
Journal:  Front Oncol       Date:  2020-11-24       Impact factor: 6.244

Review 5.  Evidence for reciprocal network interactions between injured hearts and cancer.

Authors:  Melisa N Guler; Nathalie M Tscheiller; Maria Sabater-Molina; Juan R Gimeno; Canan G Nebigil
Journal:  Front Cardiovasc Med       Date:  2022-07-15

Review 6.  Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options.

Authors:  Gioacchino P Marceca; Priya Londhe; Federica Calore
Journal:  Front Oncol       Date:  2020-03-04       Impact factor: 6.244

7.  Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer.

Authors:  Aneesha Dasgupta; Paige C Arneson-Wissink; Rebecca E Schmitt; Dong Seong Cho; Alexandra M Ducharme; Tara L Hogenson; Eugene W Krueger; William R Bamlet; Lizhi Zhang; Gina L Razidlo; Martin E Fernandez-Zapico; Jason D Doles
Journal:  JCI Insight       Date:  2022-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.